Print Page   |   Contact Us   |   Sign In   |   Join Now
Scott Wolkenberg
Share |

Scott Wolkenberg joined Merck Research Laboratories in West Point, PA, in 2003 and is currently a Senior Principal Scientist in Chemical Biology.  Scott has contributed and led teams in the design and synthesis of multiple compounds entering preclinical development including Kv1.5 blockers for atrial fibrillation, GlyT1 inhibitors for the treatment of cognitive disorders, and a PET imaging agent for early diagnosis of Alzheimer’s disease.  His research experience spans chemical biology, target validation, lead identification and optimization, and early development.  Scott has co-authored 43 peer-reviewed publications, is co-inventor on 20 patent applications, and has participated in and organized conferences in the US and abroad.  He Chaired the 2015 Gordon Conference on High Throughput Chemistry and Chemical Biology.  Scott graduated summa cum laude from Cornell University and received his Ph.D. from The Scripps Research Institute working with Dale L. Boger.

Association Management Software  ::  Legal